Generics (paroxetine), or the new unbearable lightness of patents in competition law
Sign Up to like & getrecommendations! Published in 2021 at "European Competition Journal"
DOI: 10.1080/17441056.2021.1916212
Abstract: ABSTRACT Generics represents the first instance in which the CJEU analysed the contentious pay-for-delay cases. The Court had to take position on the interplay between IPRs and competition law as well as on potential competition,… read more here.
Keywords: law; generics paroxetine; law assessment; paroxetine new ... See more keywords